Treatment with adiponectin. At the age of 3 weeks, SHRs were treated with vehicle (PBS, n=6), or recombinant human globular domain of adiponectin (gAd, 2 µg/g/day×7 days, n=6) 3, 4 . Two hours after the last treatment, animals were sacrificed, and blood samples and the mesenteric arteries were extracted.
Measurement of insulin sensitivity.
Fasting blood glucose and insulin levels were measured with the use of a blood glucose meter ((Lifescan, USA) and an RIA test kit (Peninsula Laboratories) 5 , respectively. We measured insulin sensitivity using the quantitative insulin sensitivity check index (QUICKI). QUICKI was calculated using the following formula: 6, 7 QUICKI = 1/[log(I 0 ) + log(G 0 )], where I 0 is fasting insulin (µU/ml), and G 0 is fasting glucose (mg/dl).
Intraperitoneal glucose tolerance test (IPGTT).
After 16 hours of fast, conscious mice were challenged with a glucose load of 1.5g/kg, administered intraperitoneally. Tail blood was taken at the times 0 min, 15min, 60min and 120min after the glucose load. The blood glucose levels were determined using an OneTouch II glucose meter (Lifescan, USA).
Functional assessment of murine mesenteric arterioles. Mesenteric arterioles were isolated from rats and mice, and cut into 3~4 ring segments with 1 mm long. The arteriolar segments mounted in a temperature-controlled myograph (DMT 610M) were perfused with PSS (containing (mM): NaCl 119, NaHCO 3 15, KCl 4.6, MgCl 2 1.2, NaH 2 PO 4 1.2, CaCl 2 1.5 and glucose 5.5) continuously gassed with a mixture of 95% O 2 and 5% CO 2 (pH 7.4). An optimal passive tension (~1.5 mN) was applied for 1 hour before the experiments were started. In certain preparations, the endothelium was removed by gentle mechanical abrasion. Mesenteric arteriolar segments were precontracted with 1 µmol/L PE. A dose-response curve was obtained by cumulative addition of ACh (10 -10 to 10 -5 mol/L), SNP (10 -10 to 10 -5 mol/L), and insulin (10 -10 to 10 -6 mol/L). Relaxation at each concentration was measured and expressed as the percentage of force generated in response to PE. In some experiments, insulin dose response curves were repeated after pretreatment with L-NAME (a specific NOS inhibitor, 100 µM, 30 min), wortmannin (a PI3K inhibitor, 100 nM, 30min), PD98059 (an ERK1/2 inhibitor, 10 µM; 30min), or BQ123 (an ET-1 inhibitor, 1 µM; 30min).
Determination of serum adiponectin concentrations. Total serum adiponectin concentrations were determined with a rat adiponectin ELISA kit (Adipobioscience, Santa Clara, USA) and a mouse ELISA kit (R&D Systems, Minneapolis, MN) per the instructions of the manufacturers.
Preparation of plasma membrane and nuclear protein extracts. Mesenteric arterial tissue was homogenized in buffer A containing (in mmol/L, pH 7.0): 10 NaHCO 3 , 5 NaN 3 , and then centrifuged at 7000×g for 20 min. The pellet was resuspended in buffer B (10 mmol/L Tris-HCl, pH 7.4), and centrifuged at 200×g for 20 min. The supernatant was gently layered on top of a 20% (vol/vol) Percoll gradient in buffer C (in mmol/L: 255 sucrose, 10 Tris-HCl (pH 7.4), 2 EDTA) and centrifuged at 55,000×g for 1 hour. The band at density of 1.030 was aspirated and pelleted by centrifugation at 170,000×g for 1 hour and resuspended in buffer C as plasma membrane solution. Protein concentration of plasma membrane solution was determined with BCA protein assay. AdipoRs content in plasma membrane was determined by Western blotting. Nuclear and cytoplasmic extractions were prepared with NE-PER nuclear and cytoplasmic extraction reagents (Pierce, Rockford, IL, USA). LKB1 content in nuclear and cytoplasmic fractions were determined by Western blotting.
Western blotting analysis. Protein samples were separated by electrophoresis on SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The membranes were blocked with 5% BSA and incubated overnight with the appropriate primary antibodies respectively [anti-APPL1, anti-phospho(p)-Akt (Ser 473), anti-Akt, anti-p-ERK1/2, anti-ERK1/2, anti-p-AMPK (Thr 172), anti-AMPK, anti-PTEN (Cell Signaling Technology), anti-p-eNOS (Ser 1177), anti-eNOS (BD Biosciences), anti-AdipoR1, anti-AdipoR2, anti-LKB1 (Abcam)], followed by incubation with the corresponding secondary antibodies. The blots were visualized with ECL-plus reagent. β-actin was used as the internal loading control.
Real-time PCR. Total RNA was extracted from flash-frozen tissue using TRIzol (Invitrogen, Carlsbad, CA, USA), and cDNA was synthesized from 1 µg RNA by using the reverse transcription reagent kit (DRR047A, TaKaRa). Expression analysis of the reported genes was performed by real-time PCR using a PCR detection kit (DRR081A, TaKaRa) and ABI 7500 Sequence Detection System. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an endogenous control. The primers for mRNA expression analysis by Real-time PCR are listed in Supplementary Table S1 . The threshold cycle (∆∆Ct) method of comparing expression data was applied and the relative quantitative values were expressed as 2 -∆∆Ct using the formula: Cell culture and small Interfering RNA (siRNA) transfection. Human umbilical vein endothelial cells (HUVECs) were grown in endothelial cell basal medium containing 2% fetal bovine serum and endothelial growth supplements and were used between passages 5~8. This study was approved by our institutional review board. Informed consent was given by persons donating umbilical cords. For gene silencing assay, siRNA for AdipoR1, AdipoR2, and APPL1 mRNA were designed and purchased from GenePharma (ShangHai, China). The sequences of the oligos are indicated in supplementary Table S2 . HUVECs were transfected with siRNA specific to human APPL1 or scramble control by Lipofectamine™ 2000 (Invitrogen) following the manufacturer's instructions 8 . At 48 hours after transfection, cells were serum-starved for 6 hours and treated with different concentrations of gAd for various periods as specified in each figure legend. To determine the insulin-induced signaling pathway, after incubation of 10mg/ml gAd for 48 hours, the medium was changed into ordinary culture medium and then the HUVECs were exposed to 10 -7 mol/L insulin for 30 min. The efficiency of gene knockdown was detected by Western blot analysis at 48 hour after siRNA transfection.
Quantification of NO, and ET-1 release in endothelial cells. Total NO production in culture medium was determined by measuring the concentration of nitrite, a stable metabolite of NO, with a modified Griess reaction method as reported previously 9 . Levels of ET-1 in the media were measured with a sensitive ELISA kit (Assay Designs, Ann Arbor, MI, USA) according to the manufacturer's instructions.
Statistical analysis.
All values in the text, table, and figures are presented as means ± SEM of n independent experiments. Statistical significance was determined by Student t test or ANOVA, and post hoc comparisons, adjusted for multiple comparisons by Bonferroni's correction, were performed if ANOVAs revealed significances. In all statistical comparisons, probabilities of 0.05 or less were considered to be statistically significant. Table S1 . Primer sequences used for real-time PCR.
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: Both endothelium-independent and -dependent vasodilator effects of mesenteric arterioles were comparable between ySHRs and yWKY rats. 
